Clinical Trials in Portland

Showing 6841-6860 of 10,048 trials

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

NCT01243346

This Phase II study is designed to evaluate the antitumor efficacy and pharmacokinetics of crenolanib (CP-868,596) in patients with D842-related mutant metastatic GIST.

D842-related Mutant GIST

Arog Pharmaceuticals, Inc.20 participantsStarted Apr 2011

Portland, Oregon, United States • Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas

NCT03028935

This pilot clinical trial studies how well an evidence-based exercise and nutrition program adapted for Latinas works in improving physical activity and dietary behavior in non-active, overweight, or obese rural Latinas. An exercise and nutrition program may reduce the risk for developing certain cancers, obesity, and chronic health conditions in Latinas who are non-active, overweight, or obese.

ObesityOverweight

OHSU Knight Cancer Institute15 participantsStarted Jul 2016

Portland, Oregon, United States

COMPLETEDPhase 2< 1 mile

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

NCT00546078

Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. This study will further evaluate induction of immune memory and anamnestic responses in women who previously took part in the primary study (580299/001) and follow-up study (580299/007). Subjects were aged 15-25 yrs at the time of entry into the primary study and participation in the follow-up study lasted approximately 6 years. In the primary and follow-up studies, subjects were protected against HPV-16 and HPV-18 endpoints and had sustained antibody responses to both vaccine types over at least 5.5 years of follow-up. All subjects from North American study sites that completed the follow-up study will be invited to take part in the current study. The study will evaluate the safety and immunogenicity of a dose of GSK Biologicals HPV vaccine (580299) in women who had been immunologically primed in the primary study. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

Infections, Papillomavirus

GlaxoSmithKline116 participantsStarted Jan 2008

San Francisco, California, United States • Augusta, Georgia, United States • Bardstown, Kentucky, United States +14 more locations

Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene

Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Find Trials by Condition in Portland

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Phase III Cat-PAD Study

A Phase III Study of Apixaban in Patients With Atrial Fibrillation

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead